NCT04216030

Brief Summary

To combat iron deficiency in Low and Middle-Income Countries, sustainable food-based solutions have to be implemented to serve populations, not only individuals. One solution is the introduction of iron biofortified staple crops on market level. Before market level introduction, the bioavailability of iron in the new biofortified Irish Potato (IP) breed needs to be assessed. In this study the investigator compares the fractional and total iron absorption after extrinsic stable isotope labelling of the new biofortified high iron IP variety and a normal market level IP variety. The study is conducted in Peruvian women of reproductive age with marginal iron status.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 14, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 8, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 29, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 2, 2020

Completed
Last Updated

May 13, 2020

Status Verified

May 1, 2020

Enrollment Period

3 months

First QC Date

December 29, 2019

Last Update Submit

May 11, 2020

Conditions

Keywords

BiofortificationStaple cropsStable isotope studies

Outcome Measures

Primary Outcomes (2)

  • Fractional iron absorption from both Irish Potato test meals

    Proportion of stable isotope administered with test meals that has been incorporate into erythrocytes 14 days after completion of specific test meal feeding period

    Measured 2 weeks after completion of feeding day sequence. Sequence consist of 2 times 10 feeding days.

  • Total iron absorption from both Irish Potato test meals

    Amount of iron absorbed (mg) from the labelled test meals

    Measured 2 weeks after completion of feeding day sequence. Sequence consist of 2 times 10 feeding days.

Secondary Outcomes (2)

  • Concentration of plasma ferritin level

    screening (-1), day 1 (baseline), day 15 (before switch to other test meal type) day 26 (last feeding day) and day 40 (14 days after last test meal consumption).

  • Concentration of plasma CRP level

    screening (-1), day 1 (baseline), day 15 (before switch to other test meal type) day 26 (last feeding day) and day 40 (14 days after last test meal consumption).

Study Arms (2)

High iron Irish potato

EXPERIMENTAL

Meal sequence B, IP High Fe

Other: High Fe IP meal labelled with Fe-58

Regular Irish potato

ACTIVE COMPARATOR

Meal sequence A, OFSP control

Other: Control OFSP meal labelled with Fe-57

Interventions

500 gram steamed, mashed OFSP high Fe with 0.33 mg FeSO4-58 daily for 10 days

High iron Irish potato

500 gram steamed, mashed OFSP control with 0.33 mg FeSO5-57 daily for 10 days

Regular Irish potato

Eligibility Criteria

Age18 Years - 25 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Woman aged 18-25 years old.
  • Low/marginal iron status: serum ferritin (SF) ≤ 25 μg/L.
  • Normal BMI for age (18.5-25.0 kg/m2).
  • Weight less than 65 kg. We will give equal amounts of stable isotopes to each study participant and therefore need to set a limit on body weight in order to achieve measurable isotope enrichment in erythrocytes.
  • Willing and able to commute to the meal distribution/health centre site.
  • Able to understand and to sign written concept prior to trial entry.
  • Informed consent signed.
  • Prepared to use contraceptives for the duration of the study

You may not qualify if:

  • Severe anaemia Hb \<107.2 g/L (adjusted for meters above sea level)
  • Inflammation/infection (CRP \> 5 mg/100 ml).
  • Relevant digestive (intestinal, gastric, hepatic or pancreatic), renal, metabolic disease, and any other problem that will interfere with the study as determined by the screening visit and by self-report from the subjects.
  • Pregnant (urine test before entering the study) or breast-feeding.
  • Any medication or supplement which may impact iron metabolism.
  • Unwilling to discontinue vitamin and minerals supplements at least two weeks prior to the study start, as ascertained at the screening visit.
  • Significant blood losses over the past 6 months (i.e. trauma, major surgery, blood donation).
  • Subject who cannot be expected to comply with study procedures.
  • Presence of fever (\>37.5 °C) on the first study day

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto de Investigacion Nutricional

Lima, 1506, Peru

Location

Related Publications (1)

  • Jongstra R, Mwangi MN, Burgos G, Zeder C, Low JW, Mzembe G, Liria R, Penny M, Andrade MI, Fairweather-Tait S, Zum Felde T, Campos H, Phiri KS, Zimmermann MB, Wegmuller R. Iron Absorption from Iron-Biofortified Sweetpotato Is Higher Than Regular Sweetpotato in Malawian Women while Iron Absorption from Regular and Iron-Biofortified Potatoes Is High in Peruvian Women. J Nutr. 2020 Dec 10;150(12):3094-3102. doi: 10.1093/jn/nxaa267.

MeSH Terms

Conditions

Anemia, Iron-DeficiencyIron Deficiencies

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Reyna Liria

    INN

    PRINCIPAL INVESTIGATOR
  • Mary Penny

    INN

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participant is non-blinded based on differences in meal option A and B, meal option A --\> B or B --\> A, is assigned through investigator randomisation.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: Each woman consumes both high-iron Irish potato and a regular Irish potato variety.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2019

First Posted

January 2, 2020

Study Start

May 14, 2019

Primary Completion

August 8, 2019

Study Completion

August 8, 2019

Last Updated

May 13, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations